Blaze Bioscience

Blaze Bioscience is focused on the development of Tumor Paint technology, which is designed to provide real-time, high-resolution visualization of cancer cells during surgery, enabling more precise, complete resection of cancer while sparing normal adjacent tissue. Our lead product—Tumor Paint: BLZ-100—has been shown to illuminate tumors in brain, breast and skin cancers with data demonstrating strong predictive value. The pivotal Phase 2/3 clinical study has been initiated in brain cancer.

Company Details